Overview
ABSI market data
Price History
ABSI price chart · 1M
- O
- 8.91
- H
- 8.91
- L
- 8.56
- C
- 8.79
- Vol
- 102,551.00
- Source
- US equities market feed
- Observed
- Sep 3, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $8.91
- Previous Close
- $8.80
- Day High
- $8.91
- Day Low
- $8.56
- 52 Week High
- $12.01
- 52 Week Low
- $4.49
- 7 Day Return
- -6.79%
- 30 Day Return
- +3.78%
- 90 Day Return
- +37.88%
- 1 Year Return
- +52.60%
- Daily Notional Volume
- $901.4K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.84 Diluted earnings per share over the trailing twelve months.
- Beta
- 2.25 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -6,450.8% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.24 – $12.06 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.6B · P/B 2.77 · P/S 884.24.
Company News
10 captured
AI Poised to Reshape Blood Cancer Therapeutics as Investment Surges Past $2 Billion Across Leading Biotech and Pharma PlayersGlobenewswire Inc · Aug 25, 2026, 5:15 PM
National CineMedia Posts Downbeat Q2 Results, Joins Borr Drilling, AbCellera Biologics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market SessionBenzinga · Aug 12, 2026, 12:06 PM
Absci shares are trading lower after the company reported worse-than-expected Q2 financial results.Benzinga · Aug 12, 2026, 12:01 PM
Needham Reiterates Buy on Absci, Maintains $11 Price TargetBenzinga · Aug 12, 2026, 10:23 AM
BTIG Reiterates Buy on Absci, Maintains $13 Price TargetBenzinga · Aug 12, 2026, 9:59 AM
12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga · Aug 11, 2026, 9:06 PM
Absci Q2 EPS $(0.21) Misses $(0.20) Estimate, Sales $318.000K Miss $1.169M EstimateBenzinga · Aug 11, 2026, 8:08 PM
Truist Securities Maintains Buy on Absci, Raises Price Target to $17Benzinga · Jul 2, 2026, 12:40 PM
Anthropic Is Going All In on Drug Discovery Just as Pharma Stops Talking About AIBenzinga · Jul 1, 2026, 11:55 AM
Micron To Rally More Than 57%? Here Are 10 Top Analyst Forecasts For ThursdayBenzinga · Jun 25, 2026, 1:15 PM